Role of Novel Subcutaneous Daratumumab in Multiple Myeloma
EP. 1: Ever-Expanding Indications for Daratumumab in MM
By
Ola Landgen, MD, PhD
June 1st 2020
EP. 2: Practical Management of IV Daratumumab in MM
By
Ola Landgen, MD, PhD
June 1st 2020
EP. 3: Exciting Subcutaneous Formulation Approval in MM
By
Ola Landgen, MD, PhD
June 1st 2020
EP. 4: Clinical Impact of SubQ Daratumumab for Multiple Myeloma
By
Ola Landgen, MD, PhD
June 1st 2020
EP. 5: The Impact of COVID-19 on Patients With Multiple Myeloma
By
Ola Landgen, MD, PhD
June 1st 2020
